Hadean Ventures holds €35m first close for debut fund

The life sciences specialist, headquartered in Oslo, launched its debut fund with a target size of €100m.

Managing partner Ingrid Teigland Akay told unquote" she believes investor sentiment is changing and there is increasing interest to invest in the life sciences sector. Fundraising began just over a year ago, and a second close will likely be held in a year's time, she added.

The investment team is planning on completing a first deal with a Nordic startup in the first quarter of 2018.

Hadean has offices in Oslo and Stockholm, and collaborates with startup hubs across the region.

Investors
A consortium of cornerstone investors backed the fund. LPs include Norwegian government enterprise Argentum, Swedish institutional investor Saminvest, Gjensidigestiftelsen, Norwegian pension fund OPF and Varner.

Investments
The venture capital firm intends to deploy equity tickets of €6-8m across the lifecycle of the investment, including follow-on funding. The fund will target life sciences startups across Europe but with a particular focus on the Nordic region.

People
Hadean Ventures – Ingrid Teigland Akay, Walter Stockinger (managing partners).
Argentum – Joachim Høegh-Krohn (CEO).
Saminvest – Peder Hasslev (CEO).

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Funds
• Venture
• Nordics
• Healthcare
• Norway